An Introduction of Fudan University Shanghai Cancer Center (FUSCC)
Love, Unity, Honesty and Creation
Fudan University Shanghai Cancer Center was established in 1931， which is the first hospital specializing in cancer in China. FUSCC is now an AAA (a sign of top hospitals according to the evaluation system by Chinese Ministry of Health) comprehensive cancer center under the auspices of the Ministry of Health, P. R. China. As the only comprehensive cancer center in Shanghai, FUSCC has the overwhelming advantage of specialized multidisciplinary cancer treatment. It is also a non-profit organization and a university-affiliated hospital devoted to the healthcare of the cancer patients. A history of eighty years has made a trustworthy reputation for the center.
FUSCC focus on the early diagnostic and early treatment of cancer with multidisciplinary treatment that strictly follows international standards. Surgery, radiotherapy, chemotherapy, traditional Chinese medicine (TCM), interventional therapy and biotherapy are combined to yield optimal outcomes.
The oncology program has become the key Oncology Discipline of National Education Ministry starting since 1989. After 80 years of development, the center has become the leader among other cancer centers in China in the area of radiation oncology, pathology, breast cancer and colorectal cancer. The center is also the headquarter of the municipal QC centers for pathology, radiation oncology and chemotherapy. In particular, our tumor pathology has been designated as a key discipline of the Shanghai Health Bureau, and our radiation oncology and breast cancer disciplines have been chosen to be part of the Shanghai Municipal Clinical Center. The center is affiliated with the Shanghai Anti-Cancer Association.
Currently, FUSCC has a staff of 1,418, including 1,139 are medical professionals, 138 professors and associate professors, 24 doctorial student supervisors, and 53 master student mentors. Professor Guo-liang Jiang and Professor Tai-fu Liu are the honorary fellows of American College of Radiology (ACR).
The center now has 1,100 beds, with an annual out-patient visit load of 592,441 and an annual in-patient admission of 22,515. Yearly there are 4,700 patients receiving radiotherapy and 14,454 patients receiving surgery here.
The advanced facilities includes LINACs, 60Co, after loading Brachy therapy machine, CT simulators, TPS, PET/CT, SPECT, spiral CT, MRI and digital mammography.
The center now has 25 departments and 12 multidisciplinary management teams:
Department of Radiation Oncology
Department of Breast Surgery
Department of Colorectal Surgery
Department of Gastric Cancer and Soft Tissue Sarcomas
Department of Head & Neck Surgery
Department of Thoracic Surgery
Department of Urology
Department of Pancreas and Hepatobiliary
Department of Gynecologic Oncology
Department of Medical Oncology
Department of Traditional Chinese Medicine/Integrative Oncology
Department of Anesthesiology
Department of Palliative Care
Department of Pathology
Department of Radiology
Department of Nuclear Medicine
Department of Ultrasonography
Department of Endoscope
Department of Pharmacy
Department of Clinical Laboratory
Department of Nursing
Administration & Logistics
Since 1959, 371 students have graduated from the hospital-based training and teaching programs, including 116 with Ph.D. degrees and 146 with master’s degree. The oncology program has become the key Oncology Discipline of National Education Ministry starting from 1989. As a cradle for Ph.D.s and post doctors in oncology, the hospital now has 24 professors who supervise Ph.D. students, and 53 professors who supervise master students.
Authorized by the Chinese Ministry of Health, the hospital has organized many classes for advanced trainees in the fields of pathology, radiation oncology, and surgical oncology since 1954. To date, thousands of Chinese doctors have been trained in these classes. For the last 10 years, there have been ten national-certificated continuing education programs carried out nationally.
In our efforts in fighting cancer, we are constantly exploring its pathogenesis and etiology, developing its early diagnose and treatment and finding its essence of an optimal strategy for prevention and combined-modality treatment, and these research activities have lead to the establishment of Cancer Institution of Fudan University in our center. Now we have state-of-the-art equipment and technology of cell biology, molecular biology and genetics as well as breeding rooms for animals and nude mice in this institution, and we are now implementing numerous studies on molecular, cellular and xenograft models. In 2009, we were awarded 72 scientific research projects, and the total research funds reached 12.522 million Yuan, and we published 165 scientific papers, including 82 in internationally recognized journals and 65 in well-regarded professional journals. We also compiled seven publications and obtained one patent. Additionally, we received the Chinese Medical Association Third Price Award entitled“The establishment and application of precise radiotherapy techniques for primary liver cancer.” and Shanghai Medical Association Second Price Award entitled “The research on mechanisms of lung metastasis of breast cancer and its clinical application.”.
We are working towards one of the best cancer centers in Asia by expanding our connection to the world’s best cancer centers. FUSCC established a sister institute with The University of Texas MD Anderson Cancer Center in 2003, The Cancer Institute, Singapore Healthcare Group in 2005, Institute Gustave-Roussy in 2008, and Cancer Research Institute of Kanazawa University in 2010. Every year many of our faculties go overseas to receive training and to present the seminars. We had extraordinary international exchange in 2009, including 46 groups of 132 medical experts coming from many countries such as Japan, Britain, France, USA, Germany, and Italy to have visited the center and given 36 lectures. During the year, the center successfully hosted nine major international conferences. We are trying our best to host high-quality international conferences and to participate in international symposia, because our guests see China through us, and we stand for China in the eyes of the world..